Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Kardiologiia ; 27(11): 19-22, 1987 Nov.
Artigo em Russo | MEDLINE | ID: mdl-3437659

RESUMO

Routine submaximum bicycle ergometry testing with continuous ECG monitoring conducted in 900 patients 3 weeks after the onset of acute myocardial infarction has demonstrated the safety of this procedure. Complications in the acute phase of the disease were not considered contraindications for exercise. A relationship has been found between anginal pain and ST depression in response to exercise and the rate of sudden cardiac deaths over a two-year follow-up period, the correlation being the strongest for the first 6 months after the onset of MI. Therefore, stress tolerance testing at such an early stage of the condition makes it possible to identify subjects at high risk of sudden death, and also can serve as a criterion in selecting adequate individualized strategy of rehabilitation.


Assuntos
Infarto do Miocárdio/reabilitação , Avaliação da Capacidade de Trabalho , Adulto , Idoso , Eletrocardiografia , Teste de Esforço , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Monitorização Fisiológica , Infarto do Miocárdio/terapia , Fatores de Tempo
2.
Kardiologiia ; 25(9): 59-61, 1985 Sep.
Artigo em Russo | MEDLINE | ID: mdl-2867244

RESUMO

One hundred patients with angina pectoris were studied to determine the antianginal effectiveness of senzit, fenigidin and trasicor. The calcium antagonists senzit and fenigidin were found to have high antianginal effect (44% and 78%, respectively) in patients with stable angina pectoris. It was found advisable to use the two drugs in combination with cardiac glycosides in patients with heart failure. A study showed the high antianginal effect of trasicor in postinfarction patients with refractory angina of effort.


Assuntos
Antagonistas Adrenérgicos beta/uso terapêutico , Angina Pectoris/tratamento farmacológico , Cálcio/antagonistas & inibidores , Fendilina/uso terapêutico , Nifedipino/uso terapêutico , Fenetilaminas/uso terapêutico , Propranolol/uso terapêutico , Idoso , Glicosídeos Cardíacos/administração & dosagem , Quimioterapia Combinada , Feminino , Fendilina/administração & dosagem , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/complicações , Infarto do Miocárdio/reabilitação , Nifedipino/administração & dosagem , Esforço Físico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA